University of Pisa | Department of Dermatology
Status and phase
Conditions
Treatments
About
The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes compared to placebo.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
96 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Sara Lavasani
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal